DK2229158T3 - Komprimeret tyggegummitablet - Google Patents

Komprimeret tyggegummitablet Download PDF

Info

Publication number
DK2229158T3
DK2229158T3 DK07846433.6T DK07846433T DK2229158T3 DK 2229158 T3 DK2229158 T3 DK 2229158T3 DK 07846433 T DK07846433 T DK 07846433T DK 2229158 T3 DK2229158 T3 DK 2229158T3
Authority
DK
Denmark
Prior art keywords
chewing gum
acid
compressed
pharmaceutically active
ingredients
Prior art date
Application number
DK07846433.6T
Other languages
English (en)
Inventor
Gitte Lorenzen
Nicolai Arent
Bitten Thorengaard
Helle Wittorff
Carsten Andersen
Original Assignee
Fertin Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma As filed Critical Fertin Pharma As
Application granted granted Critical
Publication of DK2229158T3 publication Critical patent/DK2229158T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)

Claims (16)

1. Komprimeret tyggegummitablet, som omfatter en eller flere farmaceutisk aktive bestanddele og en eller flere enhancere, idet den ene eller de flere enhancere omfatter et pH-reguleringsmiddel, hvor tyggegummitabletten omfatter mindst ét tyggegummimodul, som omfatter en tyggegummisammensætning, og hvor tyggegummisammensætningen omfatter tyggegummigranulater, som indeholder gummibase, hvor nævnte ene eller flere farmaceutisk aktive bestanddele omfatter nikotin, og hvor nævnte pH-reguleringsmiddel er i det mindste delvist indeholdt i det mindste i en del af nævnte tyggegummigranulater.
2. Komprimeret tyggegummitablet ifølge krav 1, hvor nævnte komprimerede tyggegummitablet omfatter mindst to eller mindst tre individuelle sammenhængende komprimerede moduler.
3. Komprimeret tyggegummitablet ifølge krav 1 eller 2, hvor den komprimerede tyggegummitablet omfatter en eller flere gummibasefri moduler.
4. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-3, hvor modulerne er lag.
5. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-4, hvor mindst én af de farmaceutisk aktive bestanddele er adskilt fra pH-reguleringsmidlet ved placering i forskellige moduler.
6. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-5, hvor i det mindste en del af de farmaceutiske bestanddele er inkorporeret i det mindste i en del af tyggegummigranulaterne.
7. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-6, hvor i det mindste en del af de farmaceutisk aktive bestanddele er adhæreret til bulksødestofspartikler og/eller tyggegummigranulater ved hjælp af smagsstof.
8. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-7, hvor i det mindste en del af de farmaceutisk aktive bestanddele er adhæreret til tørbindemiddelspartikler og/eller anbragt mellem nævnte tyggegummigranulater.
9. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-8, hvor i det mindste en del af nævnte pH-reguleringsmiddel er anbragt mellem og/eller inkorporeret i nævnte tyggegummigranulater.
10. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-9, hvor opløsning af nævnte pH-reguleringsmiddel og nævnte farmaceutisk aktive bestanddel begynder efter tygning af nævnte tyggegummitablet i en mundhule, således at nævnte mundhule har en spyt-pH, der ligger over eller under pKa af nævnte farmaceutisk aktive bestanddel.
11. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-10, hvor nævnte tyggegummisammensætning omfatter et pH-reguleringsmiddel, som muliggør, at pH som målt under tygning i en tyggeindretning holdes over den højeste pKa-værdi for den farmaceutisk aktive bestanddel i det mindste i en del af en tyggeperiode.
12. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-11, hvor i det mindste en del af pH-reguleringsmidlet er inkorporeret i tyggegummigranulaterne, og i det mindste en del af pH-reguleringsmidlet er en del af tyggegummisammensætningen som et pulver.
13. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-12, hvor nævnte farmaceutisk aktive bestanddele er i det mindste delvist indeholdt i det mindste i en del af nævnte tyggegummigranulater.
14. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-13, hvor tyggegummigranulaterne i tyggegummisammensætningen, som omfatter farmaceutisk aktive bestanddele, har gennemsnitlige partikelstørrelser på under 1500 pm, fortrinsvis under 1000 μ m, især under 800 μ m og navnlig under 600 μιη.
15. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-14, hvor i det mindste en del af de farmaceutisk aktive bestanddele er adhæreret til bulksødestofspartikler ved hjælp af smagsstof.
16. Komprimeret tyggegummitablet ifølge et hvilket som helst af kravene 1-15, hvor i det mindste en del af de farmaceutisk aktive bestanddele er adhæreret til tørbindemiddelspartikler.
DK07846433.6T 2007-12-20 2007-12-20 Komprimeret tyggegummitablet DK2229158T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2007/000563 WO2009080022A1 (en) 2007-12-20 2007-12-20 Compressed chewing gum tablet

Publications (1)

Publication Number Publication Date
DK2229158T3 true DK2229158T3 (da) 2016-12-12

Family

ID=39730722

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07846433.6T DK2229158T3 (da) 2007-12-20 2007-12-20 Komprimeret tyggegummitablet

Country Status (4)

Country Link
US (1) US8603440B2 (da)
EP (1) EP2229158B1 (da)
DK (1) DK2229158T3 (da)
WO (1) WO2009080022A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
KR101560176B1 (ko) 2007-10-31 2015-10-14 맥네일-피피씨, 인코포레이티드 구강내 붕해성 투여 형태
DK2442668T3 (da) * 2009-06-19 2016-12-12 Fertin Pharma As Bufret gummibase til høj ph-frigivelse
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
WO2011041414A1 (en) 2009-09-30 2011-04-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
DK2654738T3 (da) * 2010-12-21 2018-07-23 Fertin Pharma As Tyggegummisammensætning omfattende tværbunden polyacrylsyre
US9877929B2 (en) 2011-10-13 2018-01-30 Premier Dental Products Company Topical vitamin D and ubiquinol oral supplement compositions
EP2793849A1 (en) * 2011-12-22 2014-10-29 Fertin Pharma A/S Method of releasing nicotine from chewing gum
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
CN104684889A (zh) * 2012-07-10 2015-06-03 西蒂斯制药有限责任公司 二甲双胍的三盐形式
US9877930B2 (en) 2012-10-12 2018-01-30 Premier Dental Products Company Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
US9724542B2 (en) 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture
WO2014085599A1 (en) 2012-11-30 2014-06-05 Acura Pharmaceuticals, Inc. Self-regulated release of active pharmaceutical ingredient
US20150313847A1 (en) * 2012-12-07 2015-11-05 Gumlink A/S Compressed Tablets
US9789066B2 (en) 2014-01-10 2017-10-17 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US9642811B2 (en) 2014-03-26 2017-05-09 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
US10441535B2 (en) * 2014-12-29 2019-10-15 NeuroGum, LLC Nutraceutical confectionary composition containing caffeine and L-theanine
CN104655766B (zh) * 2015-03-20 2016-08-31 中国烟草总公司郑州烟草研究院 一种电子烟烟液中烟碱、丙二醇和丙三醇的同时测定方法
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CN109219442A (zh) 2016-04-04 2019-01-15 Omeza有限公司 鱼油局部组合物
WO2017182084A1 (en) 2016-04-21 2017-10-26 Fertin Pharma A/S Nicotine delivery product, related uses and oral dosage forms, and methods of production
US10653639B2 (en) 2016-05-16 2020-05-19 Cv Sciences, Inc. Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CN107007564A (zh) * 2017-04-12 2017-08-04 南京康川济医药科技有限公司 一种含有布洛芬和盐酸去氧肾上腺素的双层缓释药用组合物及其制备方法
US11701306B2 (en) 2018-07-06 2023-07-18 Lindsay McCormick Natural tooth powder tablets
CN108904443A (zh) * 2018-10-10 2018-11-30 吴刚 一种外用制剂及其用途
IL262768B (en) 2018-11-04 2020-08-31 Ambrosia Supherb Ltd A chewable tablet and method of preparing the same
JP2024524056A (ja) * 2021-06-07 2024-07-05 キャンベル・ファリダ・ハンナ 抗マルチウイルス感染および免疫促進アセンブリ

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227154A (en) 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
US5300305A (en) 1991-09-12 1994-04-05 The Procter & Gamble Company Breath protection microcapsules
US5378131A (en) 1993-02-18 1995-01-03 The Wm. Wrigley Jr. Company Chewing gum with dental health benefits employing calcium glycerophosphate
US5580590A (en) 1993-12-27 1996-12-03 The Wm. Wrigley Jr. Company Environmentally friendly chewing gum compositions containing elastic protein-based polymers and method of making it
EP0672354B1 (en) 1994-03-18 2000-07-12 Ajinomoto Co., Inc. Proteinaceous material for enhancing food taste quality
NL9401703A (nl) 1994-10-14 1996-05-01 Rijksuniversiteit Kauwgom.
US5800848A (en) 1995-06-20 1998-09-01 The Wm. Wrigley Jr. Company Chewing gum containing sucrose polyesters
US5866179A (en) 1996-05-03 1999-02-02 Avant-Garde Technologies & Products S.A. Medicated chewing gum and a process for preparation thereof
AU7469396A (en) 1996-10-22 1998-05-15 Wm. Wrigley Jr. Company Gum base and chewing gum containing edible polyesters
US6017566A (en) 1997-10-20 2000-01-25 Wm. Wrigley Jr. Company Gum base and chewing gum containing edible polyesters and method for manufacture
US6194008B1 (en) 1998-02-09 2001-02-27 Wm. Wrigley Jr. Company Environmentally friendly chewing gum bases including polyhydroxyalkanoates
US6613363B1 (en) 1998-10-02 2003-09-02 Wm. Wrigley Jr. Company Biodegradable chewing gum bases including plasticized poly(D,L-lactic acid) and copolymers thereof
AU1031500A (en) 1998-11-03 2000-05-22 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
US6235318B1 (en) 1999-01-21 2001-05-22 Charles M. Lombardy, Jr. Effervescent chewing gum
US6846500B1 (en) 1999-03-25 2005-01-25 Cadbury Adams Usa Llc Oral care chewing gums and method of use
US6773730B1 (en) 1999-06-30 2004-08-10 Wm. Wrigley Jr. Company Ingestible and degradable chewing gum including enzymatic hydrolysates of proteins
US6838431B2 (en) 1999-07-27 2005-01-04 Pacific Health Laboratories, Inc. Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
US6207638B1 (en) 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
US6471945B2 (en) 2000-03-10 2002-10-29 Warner-Lambert Company Stain removing chewing gum and confectionery compositions, and methods of making and using the same
US6479071B2 (en) 2000-03-10 2002-11-12 Warner-Lambert Company Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
US6485739B2 (en) 2000-03-10 2002-11-26 Warner-Lambert Company Stain removing chewing gum and confectionery compositions, and methods of making and using the same
WO2002047614A2 (en) 2000-12-15 2002-06-20 Pacific Health Laboratories, Inc. Nutritional composition for improving the efficacy of a lipase inhibitor
CN100506060C (zh) 2001-03-23 2009-07-01 古木林科有限公司 口香糖的一步制造方法
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
US7208186B2 (en) * 2001-09-18 2007-04-24 Spi Pharma, Inc. Chewing gum formulation and method of making the same
US20030157213A1 (en) 2002-02-19 2003-08-21 Jeffrey Jenkins Nutrient chewing gum
US20030215417A1 (en) 2002-04-18 2003-11-20 The Procter & Gamble Company Malodor-controlling compositions comprising odor control agents and microcapsules containing an active material
US7347985B2 (en) 2002-06-25 2008-03-25 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract
US6858238B2 (en) 2002-06-26 2005-02-22 Wm. Wrigley Jr. Company Chewing gum products including prolamine blends
AU2003243931A1 (en) * 2002-07-02 2004-01-23 Gumlink A/S Compressed resin moderated chewing gum
WO2004028268A1 (en) 2002-09-24 2004-04-08 Gumlink A/S Chewing gum comprising at least two different biodegradable polymers
US7445769B2 (en) 2002-10-31 2008-11-04 Cadbury Adams Usa Llc Compositions for removing stains from dental surfaces and methods of making and using the same
US6685916B1 (en) 2002-10-31 2004-02-03 Cadbury Adams Usa Llc Compositions for removing stains from dental surfaces, and methods of making and using the same
ES2325396T3 (es) * 2003-02-04 2009-09-03 Gumlink A/S Pastilla de goma de mascar comprimida.
DE10319315A1 (de) 2003-04-29 2004-11-18 Basf Ag Verwendung eines amorphen Polyesters als Polymerbasis für Kaumassen
DK1474994T3 (da) 2003-05-06 2009-08-03 Gumlink As Fremgangsmåde til fremstilling af tyggegummiprodukter, og komprimerede tyggegummitabletter
EP1474993B1 (en) 2003-05-06 2008-08-20 Gumlink A/S A method for producing chewing gum granules and compressed gum products, and a chewing gum granulating system
US7390518B2 (en) 2003-07-11 2008-06-24 Cadbury Adams Usa, Llc Stain removing chewing gum composition
PL2446881T3 (pl) * 2003-07-24 2014-08-29 Glaxosmithkline Llc Folie rozpuszczające się w jamie ustnej
EP1554935A1 (en) * 2004-01-19 2005-07-20 Gumlink A/S Layered chewing gum tablet
WO2006000233A1 (en) 2004-06-29 2006-01-05 Fertin Pharma A/S Tobacco alkaloid containing chewing gum
DK1765304T4 (da) 2004-07-06 2019-06-03 Fertin Pharma As Komprimattyggegummitablet
US8496913B2 (en) * 2005-01-28 2013-07-30 Gumlink A/S Compressed chewing gum tablet
EP1693086A1 (en) 2005-01-28 2006-08-23 Gumlink A/S Multi functional oral care chewing gum
EP1895992A4 (en) * 2005-05-23 2012-03-28 Kraft Foods Global Brands Llc PHARMACEUTICAL SYSTEMS COMPRISING COMPRESSIBLE KAUGUMMIBASIS FOR INGREDIENT RELIEF

Also Published As

Publication number Publication date
US8603440B2 (en) 2013-12-10
US20100255063A1 (en) 2010-10-07
EP2229158B1 (en) 2016-08-10
WO2009080022A1 (en) 2009-07-02
EP2229158A1 (en) 2010-09-22

Similar Documents

Publication Publication Date Title
EP2229158B1 (en) Compressed chewing gum tablet
DK2229157T3 (da) Komprimeret tyggegummitablet
DK2229156T3 (da) Tyggegummitablet og fremgangsmåde til dosering af farmaceutisk aktive bestanddele i sådan tyggegummitablet
EP2282645B1 (en) Flavor impregnation of a chewing gum core
EP2162013B1 (en) Compressed chewing gum comprising an encapsulation delivery system comprising natural resin
EP2162016B1 (en) Chewing gum granules for compressed chewing gum
CA2758618C (en) Particulate material for controlled release of active ingredients
WO2009007768A1 (en) Compressed tablet comprising polyol
WO2009007769A1 (en) Multi-modular chewing gum tablet
US8968770B2 (en) Multi-part kit comprising a chewing gum and further a flavor containing formulation
WO2009007771A1 (en) High volume compressed chewing gum tablet